SCHEMBL13638437

SCHEMBL13638437

C=C1CC(Nc2nccc(-c3ccc(CCC(C)(C)O)cc3)n2)CC(C)(C)N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 11/20 0.39
MAPK8 P45983 2/20 0.36
CHUK O15111 1/20 0.36
CDK1 P06493 1/20 0.34
CDK4 P11802 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34
CCND1 P24385 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34
MAP3K14 Q99558 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
CCNT1 O60563 1/20 0.33
CCNK O75909 1/20 0.33
CDK7 P50613 1/20 0.33
CDK9 P50750 1/20 0.33
CCNH P51946 1/20 0.33
MNAT1 P51948 1/20 0.33
CDK12 Q9NYV4 1/20 0.33
MAPK9 P45984 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638532 0.91 IKBKB (0.39) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638438 0.88 IKBKB (0.39) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638679 0.87 IKBKB (0.41) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL4495249 0.87 IKBKB (0.43) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638312 0.86 IKBKB (0.39) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638536 0.85 IKBKB (0.37) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638531 0.85 SYK (0.43) IKBKBMAPK8CHUKHDAC8
SCHEMBL13638482 0.85 IKBKB (0.37) IKBKBMAPK8CHUKHDAC8MAPK9
SCHEMBL13638313 0.85 IKBKB (0.39) IKBKBMAPK8CHUKMAPK9MAPK10
SCHEMBL13638590 0.85 ROCK2 (0.38) IKBKBMAPK8CHUKHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed